Summary
Clinical Research Partners is enrolling participants for an adult mRNA COVID-19 vaccine study. Eligible participants include adults ages 12–64 with a high-risk medical condition and adults 65 and older. The study includes one vaccine dose, a six-month commitment, no cost to participate, and compensation may be available.
Age
12-64 years old with high-risk medical condition or 65 years and older
Qualifications
- 6-month commitment
- No cost to participate
Compensation
Compensation may be available.